Inactive Instrument

Highlights Rafarma Pharmaceuticals, Inc. Other OTC

Equities

RAFA

US75062C1009

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	17/21/17	CI
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	07/21/07	CI
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	29/21/29	CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc	15/20/15	CI
Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer	09/20/09	GL
Rafarma Pharmaceuticals, Inc. Signs a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia	01/20/01	CI
Rafarma Pharmaceuticals : Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger	04/20/04	AQ
Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger	04/20/04	GL
Rafarma Pharmaceuticals : Closes Biocogency Merger	19/20/19	AQ
Rafarma Closes Biocogency Merger	19/20/19	GL
R. & D. Biocogency Laboratories Inc. Ltd. completed the acquisition of an unknown majority stake in Rafarma Pharmaceuticals, Inc..	19/20/19	CI
Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects	25/20/25	GL
Rafarma Pharmaceuticals : Establishes Thailand Corporate Entity For Merger and Expansion Projects	25/20/25	AQ
Rafarma Establishes Thailand Corporate Entity for Merger and Expansion Projects	25/20/25	CI
R. & D. Biocogency Laboratories Inc. Ltd. agreed to acquire an unknown majority stake in Rafarma Pharmaceuticals, Inc..	04/20/04	CI
Rafarma Pharmaceuticals, Inc. Announces Finalization of the Agreement with Destination Marketing Group Co. Ltd	22/20/22	CI
Rafarma Pharmaceuticals, Inc. Announces Commencement of Tests for Its New Product Hempysleep	15/20/15	CI
Rafarma Pharmaceuticals, Inc. Agrees Terms to Open Its First Specialized Cannabis Spa in Europe	23/20/23	CI
Rafarma Pharmaceuticals Inc. Officially Begun Research Programs with Khon Kaen University in Thailand	24/20/24	CI
Rafarma Announces Cooperative Research Programs with the Faculty of Medicine, Khon Kaen University, Thailand	10/20/10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Rafarma Pharmaceuticals, Inc. Other OTC

Equities

RAFA

US75062C1009

Highlights

Filters